NICE publishes further rapid COVID-19 guidance for patients with respiratory and skin conditions

The latest set of guidance covers the management of patients with COPD, cystic fibrosis, and dermatological conditions treated with immunomodulatory drugs.

by Chloe Harman
Oxygen follow-up assessments can be postponed in patients with COPD to reduce the risk of COVID-19 infection, NICE says. | GETTY IMAGES
Oxygen follow-up assessments can be postponed in patients with COPD to reduce the risk of COVID-19 infection, NICE says. | GETTY IMAGES

Please sign in or register to continue.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package